SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
joy
Lv4
480 积分
2023-04-14 加入
最近求助
最近应助
互助留言
Finerenone and diabetic renal disease: a narrative review
21小时前
已完结
Targeting endothelin signaling in podocyte injury and diabetic nephropathy-diabetic kidney disease
21小时前
已完结
A child with semaphorin 3b-associated membranous nephropathy effectively treated with obinutuzumab after rituximab resistance
1天前
已完结
Can we effectively manage chronic kidney disease with a precision-based pharmacotherapy plan? Where are we?
5天前
已完结
Differences in the epidemiology, management and outcomes of kidney disease in men and women
6天前
已完结
Novel approaches to primary membranous nephropathy: Beyond the KDIGO guidelines
6天前
已完结
Membranous nephropathy: new pathogenic mechanisms and their clinical implications
6天前
已完结
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
17天前
已完结
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
18天前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
18天前
已完结
没有进行任何应助
不是全文,仅为口头交流摘要
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论